Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

NCT00095030 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1752

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: muraglitazar

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]